VITALE, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 11.347
AS - Asia 4.039
EU - Europa 3.853
SA - Sud America 583
Continente sconosciuto - Info sul continente non disponibili 104
AF - Africa 89
OC - Oceania 7
Totale 20.022
Nazione #
US - Stati Uniti d'America 11.124
GB - Regno Unito 1.459
SG - Singapore 1.216
CN - Cina 1.129
IT - Italia 698
BR - Brasile 445
VN - Vietnam 445
HK - Hong Kong 443
SE - Svezia 356
DE - Germania 308
BD - Bangladesh 204
FR - Francia 181
RU - Federazione Russa 165
UA - Ucraina 165
FI - Finlandia 164
CA - Canada 124
KR - Corea 111
IN - India 100
TR - Turchia 97
IE - Irlanda 88
BG - Bulgaria 68
AR - Argentina 40
ID - Indonesia 37
MX - Messico 36
JP - Giappone 32
NL - Olanda 32
IQ - Iraq 30
ZA - Sudafrica 30
AE - Emirati Arabi Uniti 29
CO - Colombia 26
ES - Italia 26
PK - Pakistan 24
MY - Malesia 21
PL - Polonia 21
VE - Venezuela 21
BE - Belgio 19
CL - Cile 18
EC - Ecuador 17
BY - Bielorussia 15
SA - Arabia Saudita 13
UZ - Uzbekistan 13
PH - Filippine 12
CR - Costa Rica 11
LT - Lituania 11
TH - Thailandia 10
TT - Trinidad e Tobago 10
CZ - Repubblica Ceca 9
MA - Marocco 9
PT - Portogallo 9
PY - Paraguay 9
EG - Egitto 8
JM - Giamaica 8
NP - Nepal 8
AT - Austria 7
AZ - Azerbaigian 7
RO - Romania 7
TN - Tunisia 7
AL - Albania 6
DO - Repubblica Dominicana 6
GT - Guatemala 6
HN - Honduras 6
IL - Israele 6
KE - Kenya 6
KZ - Kazakistan 6
AU - Australia 5
DZ - Algeria 5
GE - Georgia 5
HU - Ungheria 5
JO - Giordania 5
NI - Nicaragua 5
CH - Svizzera 4
EE - Estonia 4
ET - Etiopia 4
LB - Libano 4
LK - Sri Lanka 4
LU - Lussemburgo 4
NO - Norvegia 4
PR - Porto Rico 4
PS - Palestinian Territory 4
SI - Slovenia 4
TW - Taiwan 4
BO - Bolivia 3
CY - Cipro 3
GR - Grecia 3
LY - Libia 3
MM - Myanmar 3
NG - Nigeria 3
OM - Oman 3
PA - Panama 3
RS - Serbia 3
SC - Seychelles 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AM - Armenia 2
CG - Congo 2
CI - Costa d'Avorio 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
HR - Croazia 2
KG - Kirghizistan 2
Totale 19.898
Città #
Ashburn 1.411
Southend 1.111
Santa Clara 861
Fairfield 804
Singapore 765
Woodbridge 562
Chandler 465
Hong Kong 430
San Jose 423
Houston 409
Hefei 366
Seattle 362
Jacksonville 348
Council Bluffs 313
Wilmington 293
Dearborn 291
Cambridge 290
Ann Arbor 288
Los Angeles 262
Chicago 256
Beijing 231
Nyköping 201
London 165
New York 148
Ho Chi Minh City 126
The Dalles 118
Modena 117
Helsinki 101
Hanoi 96
Dallas 94
Seoul 93
Salt Lake City 92
Dublin 85
Princeton 75
Milan 73
San Diego 68
Buffalo 66
Sofia 64
Toronto 61
Eugene 57
Izmir 53
Lauterbourg 51
São Paulo 50
Moscow 48
Phoenix 46
Elk Grove Village 42
Boardman 41
Des Moines 41
Columbus 39
Frankfurt am Main 36
Atlanta 33
Longmont 33
Orem 33
Bremen 32
Munich 30
Tampa 30
Tokyo 29
Brooklyn 28
Redwood City 28
Rome 28
Fremont 27
Falls Church 26
Lancaster 25
Chennai 23
Da Nang 23
Denver 22
Haiphong 22
Miami 22
Sterling 22
Shanghai 21
Bologna 20
Springfield 19
San Francisco 18
Brussels 17
Naples 17
Norwalk 17
Warsaw 17
Boston 16
Montreal 16
Jakarta 15
Johannesburg 15
Pittsburgh 15
Ferrara 14
Washington 14
Detroit 13
Las Vegas 13
Mexico City 13
Parma 13
Seongnam 13
Kansas City 12
Newark 12
Paris 12
Tashkent 12
Amsterdam 11
Biên Hòa 11
Poplar 11
Rio de Janeiro 11
Wuhan 11
Baghdad 10
Dhaka 10
Totale 13.843
Nome #
ANXIOLYTIC LIKE EFFECT OF NEUROPEPTIDE S IN THE RAT DEFENSIVE BURYING. 535
Chronic treatment with the selective NOP receptor antagonist [Nphe1,Arg14,Lys15]N/OFQ-NH2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats 515
Effect of acetylsalicylic acid on formalin test and on serotonin system in the rat brain. 486
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. 450
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 447
Acute noise stress analgesia in relation to 5-HT2 and mu-opioid receptor changes in the frontal cortex of young mice 434
The antinociceptive effect of acetylsalicylic acid is differently affected by a CB1 agonist or antagonist and involves the serotonergic system in rats 420
Panax notoginseng (Burk.) effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet 417
Serotonergic and opiatergic modifications induced by paracetamol as a model for daily chronic headache with analgesic overuse 415
Effect of salidroside, active principle of Rhodiola rosea extract, on binge eating. 413
Effect of acute and repeated administration of paracetamol on opioidergic and serotonergic systems in rats. 391
Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol 385
CCAP regulates feeding behavior via the NPF pathway in Drosophila adults 383
Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats 379
Collagen VI regulates peripheral nerve regeneration by modulating macrophage recruitment and polarization 375
Effects of [Nphe1, Arg14, Lys15] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 374
Differential involvement of opioidergic and serotoninergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol 372
[tBu-D-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: in vitro and in vivo studies. 363
Neuropeptide S stimulates human monocyte chemotaxis via NPS receptor activation. 350
Gamma-hydroxybutyrate increases gastric emptying in rats 339
Effect of acute and chronic treatment with triiodothyronine on serotonin levels and serotonergic receptor subtypes in the rat brain 337
Structure Model and Toxicity of the Product of Biodissolution of Chrysotile Asbestos in the Lungs 337
Central antinociceptive activity of acetylsalicylic acid is modulated by brain serotonin receptor subtypes 336
BRAIN-SEROTONIN BINDING-CAPACITY, ANALGESIA AND DRUG SERUM LEVELS AFTER ACUTE TREATMENT WITH PHENAZONE IN RATS 329
Functional antagonism between nociceptin/orphanin FQ and corticotropin-releasing factor in rat anxiety-related behaviors: involvement of the serotonergic system 323
Nociceptin/orphanin FQ prevents the antinociceptive action of paracetamol on the rat hot plate test 313
Disclosing the Antioxidant and Neuroprotective Activity of an Anthocyanin-Rich Extract from Sweet Cherry (Prunus avium L.) Using In Vitro and In Vivo Models 312
Disposition of naproxen after oral administration during and between migraine attacks. 311
Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials 308
Effect of rofecoxib on nociception and the serotonin system in the rat brain 301
Acetylsalicyclic acid potentiates the antinociceptive effect of morphine in the rat:involvement of the central serotonergic system. 292
Naltrexone: aspetti di farmacologia ed applicazioni cliniche 292
In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP-505 292
BV-2 Microglial Cells Respond to Rotenone Toxic Insult by Modifying Pregnenolone, 5alpha-Dihydroprogesterone and Pregnanolone Level 292
In vitro toxicity of fibrous glaucophane 286
Headaches associated with chronic use of analgesics: A therapeutic approach 284
Acute cytotoxicity of mineral fibres observed by time-lapse video microscopy 279
Drug metabolism in liver cirrhosis: alterations of the time-course of plasma naltrexone levels after oral intake 277
The potentiation of analgesic activity of paracetamol plus morphine involves the serotonergic system in rat brain 274
Human microglia synthesize neurosteroids to cope with rotenone-induced oxidative stress 272
Effects of chronic treatment with phenazone on the hot plate test and [3H]-Serotonin binding sites in pons and cortex membranes of the rat 269
The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain 268
THE ROLE OF SEROTONIN BRAIN RECEPTORS IN THE ANALGESIC EFFECT OF PHENAZONE 266
Lack of activity of Ketorolac in hot-plate test and serotonin binding capacity of brain membranes in rats 263
PHYSIOLOGICAL-PARAMETERS AND PLASMA-LEVELS AFTER SHORT AND LONG-TERM PROPOFOL INFUSION 262
Glutamate-mediated astrocyte-to-neuron signaling in the rat dorsal horn 259
The effect of paracetamol and morphine combination on dynorphin A levels in the rat brain. 257
Serotonin and opiate involvement in the antinociceptive effect of acetylsalicylic acid 254
Plasma reduced glutathione level and changes in thiol groups after glutathione administration in drug abuser patients - 253
Streptozotocin-induced diabetes provokes changes in serotonin concentration and on 5-HT1A and 5-HT2 receptors in the rat brain 246
The effect of chronic treatment with phenazone on [3H]-serotonin binding sites in pons and cortex membranes of the rat 243
Involvement of brain serotonergic system in the antinociceptive action of acetylsalicylic acid in the rat 238
The effect of Paracetamol on nociception and dynorphin A levels in the rat brain 236
Plasma time-course of naltrexone and 6beta-naltrexol after oral naltrexone administration in patients with liver cirrhosis 229
Chronic treatment with phenazone modifies pontine noradrenergic receptors in rats. 228
Naloxone-reverisble antinociception by paracetamol in the rat. 226
EFFECTS OF ACETYLSALICYCLIC ACID ON SEROTONIN BRAIN RECEPTOR SUBTYPES 224
Naltrexone and 6-Beta-naltrexol concentration/time profile in the treatment of opiate dependence 215
Serum levels of naltrexone and 6-beta-naltrexol after oral naltrexone in patients with liver cirrhosis 213
Effect of hypericum perforatum extract in an experimental model of binge eating in female rats 203
Lack of activity of azapropazone in the hot-plate test and in 5-HT1A and 5-HT2 receptor subtypes in rat brain membranes 193
Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study 192
Plasma time-course of naltrexone and 6beta-naltrexol levels after oral administration in drug addicts and in patients with liver cirrhosis 190
Chemical Characterization and Beneficial Effects of Walnut Oil on a Drosophila melanogaster Model of Parkinson’s Disease 153
Characterization of Walnut Oil and Evaluation of Its Neuroprotective Effects in an In Vitro Model of Parkinson’s Disease 152
Totale 20.022
Categoria #
all - tutte 75.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.120


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022965 0 0 0 76 37 37 101 64 148 99 257 146
2022/20231.341 163 152 86 124 147 207 22 118 137 30 55 100
2023/2024650 36 36 49 54 162 43 34 93 11 17 52 63
2024/20252.692 86 16 44 176 566 388 225 136 298 160 293 304
2025/20266.379 405 273 437 779 1.126 448 648 297 598 523 463 382
2026/20271.976 250 598 450 678 0 0 0 0 0 0 0 0
Totale 20.022